Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Programmed cell death protein 1 inhibitor | ClinicalTrials Other |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
| Lung Neoplasms | 3 | D008175 | ClinicalTrials |
| Carcinoma, Squamous Cell | 3 | D002294 | ClinicalTrials |
| Nasopharyngeal Neoplasms | 3 | D009303 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297571 |
CONTENTS